Current Cost-Share Assistance Legislation

Health care innovations made possible by biologic therapies, and new uses for IVIG, have improved the lives of thousands of patients living with chronic diseases and complex immune disorders. Unfortunately, due to the complicated manufacturing process, these new therapies can be incredibly expensive. As a result, many patients are unable to access these treatments, despite desperately needing them to manage debilitating illness. To provide relief and increase access to these medications, many manufacturers have created co-pay assistance programs to help patients manage the financial burden by covering a portion of the patient’s cost.

Below are state and federal level cost-share assistance bills that NICA either supports or opposes. Click on a colored state to learn more.